Affymax (AFFY) News Today → Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (From Small Cap Sniper) (Ad) Free AFFY Stock Alerts $0.0008 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 7, 2024 | finance.yahoo.comEdgewise Therapeutics Appoints Arlene Morris to its Board of DirectorsApril 4, 2024 | finance.yahoo.comFull Glass Wine Co. Secures $14 Million Funding; Acquires Leading DTC Wine Subscription Brand, Bright CellarsFebruary 27, 2024 | finance.yahoo.comNested Therapeutics Strengthens Board of Directors with Appointment of New Chair and DirectorsFebruary 23, 2024 | benzinga.comAffymax Stock (OTC:AFFY), Short Interest ReportSeptember 25, 2023 | finance.yahoo.comJasper Therapeutics Appoints Herb Cross as Chief Financial OfficerSeptember 18, 2023 | markets.businessinsider.comAnaptysBio Announces Appointment of John Orwin as Chairman of the Board of DirectorsJune 7, 2023 | thestreet.com4 Biotech Stocks Under $5 to WatchMay 15, 2023 | thestreet.com10 Biotech Stocks on Clinical Trials WatchJanuary 19, 2023 | bizjournals.comWhy a UCSF vice chancellor is returning to the biotech industryJanuary 18, 2023 | marketwatch.comHinge Bio Expands Senior Management Team to Drive GEM-DIMER(TM) Programs to Clinical DevelopmentJanuary 18, 2023 | nz.finance.yahoo.comHinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical DevelopmentSeptember 14, 2022 | finanznachrichten.deTurn Biotechnologies, Inc.: Turn Biotechnologies launches eTurna delivery platform designed specifically to enable nucleic acid therapeuticsAugust 28, 2022 | reuters.comAFFY.PK - Affymax, Inc. | Stock Price & Latest News | ReutersAugust 25, 2022 | finance.yahoo.comFrontier Medicines Announces the Appointment of Seasoned Legal Executive Mark Dizon, J.D., as General CounselAugust 3, 2022 | investing.comEsso Thailand PCL F (ESSOf)August 3, 2022 | investing.comDialog Group Bhd (DIAL)July 30, 2022 | investing.comDPS Resources Bhd (DPSS)April 27, 2022 | marketwatch.comRenal Disease Treatment Market Size with New Growth Prospect By Top Key Players | Impact of COVID-19 PandemicMarch 27, 2022 | marketwatch.comRenal Disease Treatment Market Scope with New Growth Prospect By Top Key Players | Impact of COVID-19 PandemicSeptember 2, 2021 | ca.finance.yahoo.comArcutis Announces Appointment of Keith Leonard to Board of Directors Get Affymax News Delivered to You Automatically Sign up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Millionaire Says: “Buy This $11 AI Coin.” (Ad)Right now, you can harness the power of two bull markets... Artificial intelligence...And cryptos. Find out more about this $11 AI Coin right now AFFY Media Mentions By Week AFFY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AFFY News Sentiment▼0.000.57▲Average Medical News Sentiment AFFY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AFFY Articles This Week▼00▲AFFY Articles Average Week Get Affymax News Delivered to You Automatically Sign up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Today Capstone News Today Context Therapeutics News Today EOM Pharmaceuticals News Today Genmab A/S News Today Grifols News Today Hypera News Today International Stem Cell News Today LAVA Therapeutics News Today Mainz Biomed News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AFFY) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThis 1 Biotech Stock has been shocking the marketsHuge AlertsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affymax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
